• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

都柏林圣詹姆斯医院1996年至1999年急性心肌梗死病例审计。

Audit of acute myocardial infarctions at Saint James's Hospital, Dublin, from 1996 to 1999.

作者信息

Pate G E, Curtin R, Talbot A, Murphy R T, Ward D, Barry M, Crean P, Foley J B, Walsh M J

机构信息

Department of Cardiology, CResT Directorate, Saint James' Hospital, Dublin 8.

出版信息

Ir Med J. 2002 Oct;95(9):274-6.

PMID:12469999
Abstract

Saint James' Hospital is a 650-bed tertiary referral hospital. An audit was performed of acute transmural myocardial infarctions for the years 1996 to 1999 inclusive. On average there were 2043 cardiology admissions annually, 9.8% of all hospital admissions. Acute transmural myocardial infarction was diagnosed in 178 patients annually, and was less common during the summer. The figure of 72% receiving revascularisation therapy (thrombolysis 67%, primary angioplasty 5%) compares favourably with 35% in 1992. The main reason for not receiving thrombolysis was late presentation (15%) with contraindications present in only 5%. The case fatality rate was 16% confirming the higher mortality in clinical practice than that of thrombolytic trials. The prescription of aspirin or warfarin (99%) and betablockers (67%) was in line with international trials. The use of angiotensin converting enzyme inhibitors (34%) and statins (28%) is similar to other studies but less than would be expected according to trial evidence.

摘要

圣詹姆斯医院是一家拥有650张床位的三级转诊医院。对1996年至1999年(含)期间的急性透壁性心肌梗死进行了一项审计。平均每年有2043例心脏病科住院患者,占所有医院住院患者的9.8%。每年有178例患者被诊断为急性透壁性心肌梗死,夏季较为少见。接受血运重建治疗的比例为72%(溶栓治疗占67%,直接血管成形术占5%),与1992年的35%相比更具优势。未接受溶栓治疗的主要原因是就诊延迟(15%),仅有5%的患者存在禁忌证。病死率为16%,证实临床实践中的死亡率高于溶栓试验中的死亡率。阿司匹林或华法林(99%)和β受体阻滞剂(67%)的处方符合国际试验标准。血管紧张素转换酶抑制剂(34%)和他汀类药物(28%)的使用情况与其他研究相似,但低于试验证据所预期的水平。

相似文献

1
Audit of acute myocardial infarctions at Saint James's Hospital, Dublin, from 1996 to 1999.都柏林圣詹姆斯医院1996年至1999年急性心肌梗死病例审计。
Ir Med J. 2002 Oct;95(9):274-6.
2
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.院前溶栓治疗对急性心肌梗死1年预后的影响:来自法国全国性USIC 2000注册研究的结果
Circulation. 2004 Oct 5;110(14):1909-15. doi: 10.1161/01.CIR.0000143144.82338.36. Epub 2004 Sep 27.
3
[Management of acute transmural myocardial infarction: a study on 200 patients admitted to a tertiary care medical center].[急性透壁性心肌梗死的管理:对一家三级医疗中心收治的200例患者的研究]
J Med Liban. 2005 Jan-Mar;53(1):2-8.
4
In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.接受溶栓治疗或直接冠状动脉血管成形术的高危急性心肌梗死患者的院内及一年期预后
Ital Heart J. 2004 Feb;5(2):136-45.
5
[Multi-drug management after myocardial infarct].
Wien Klin Wochenschr. 1997;109 Suppl 2:17-24.
6
[Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].[急性心肌梗死患者管理中直接冠状动脉血管成形术的经验]
Angiol Sosud Khir. 2008;14(1):131-41.
7
Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).ST段抬高型心肌梗死患者早期再灌注治疗的临床获益情况(该情况通常被排除在随机临床试验之外)(来自急性心肌梗死最大个体化治疗加量试验[MITRA Plus]注册研究的结果)
Am J Cardiol. 2009 Oct 15;104(8):1074-7. doi: 10.1016/j.amjcard.2009.05.054.
8
[Thrombolytic treatment of acute myocardial infarct. 3].[急性心肌梗死的溶栓治疗。3]
Acta Med Port. 1998 May;11(5):431-8.
9
[Betablocker therapy in acute myocardial infarction].[急性心肌梗死中的β受体阻滞剂治疗]
Arch Mal Coeur Vaiss. 1998 Apr;91 Spec No 2:43-7.
10
The management of acute myocardial infarction--practical problems in implementing the evidence.
Ir Med J. 2002 Oct;95(9):270-2.